 phase trial monoclon antibodi acut myelogen leukemia specif bone marrow intern radionuclid patient myeloid leukemia phase trial dose mous monoclon antibodi mab reactiv glycoprotein myeloid leukemia blast earli hematopoiet progenitor cell normal stem cell trace-label detail pharmacokinet dosimetr studi serial sampl blood bone marrow whole-bodi gamma-camera imag total mg immedi advers effect absorpt target vivo biopsi pharmacolog flow cytometri satur avail site dose equal entir bone marrow hour inject optim imag dose bone marrow biopsi signific dose-rel uptak hour infus patient major dose marrow tumor regress estim rad/mci whole bodi rad/mci plasma rad/mci red marrow compart major bound immunoglobulin igg target cell vivo data whole bone marrow abl dose rapid specif quantit deliveri bone marrow effici intern target cell vivo deliveri isotop auger alpha emitt toxin import molecul leukemia cell normal hematopoiet progenitor cell feasibl